Uterine-preserving treatments or hysterectomy reintervention after myomectomy or uterine artery embolisation: A retrospective cohort study of long-term outcomes
- PMID: 36706789
- DOI: 10.1111/1471-0528.17412
Uterine-preserving treatments or hysterectomy reintervention after myomectomy or uterine artery embolisation: A retrospective cohort study of long-term outcomes
Abstract
Objective: To assess comparative rates of further uterine-preserving procedures (UPP) or hysterectomy reintervention, after myomectomy or uterine artery embolisation (UAE).
Design: Population-based, retrospective cohort study.
Setting: England.
Population: Women who underwent myomectomy or UAE between 2010 and 2015 under the NHS.
Methods: Data was abstracted from NHS Health Episode Statistics datasets. Hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated using Cox proportional-hazards regression.
Main outcomes measures: 30-day readmission, UPP and hysterectomy reintervention rates.
Results: 9443 and 6224 women underwent elective myomectomy or UAE, respectively. After 118 136 total person-years of follow-up, the rate of hysterectomy was 8.34 and 20.98 per 1000 patient years for myomectomy or UAE, respectively. There was a 2.4-fold increased risk of undergoing hysterectomy after UAE when compared with myomectomy in adjusted models (HR 2.38 [95% CI 2.10-2.66]) [adjusted for age, ethnicity, multiple deprivation index, geographical region and comorbidities]. The HR for undergoing a UPP reintervention was 1.44 (95% CI 1.29-1.60) in favour of myomectomy. The rate of hysterectomy was increased 22% following UAE compared with laparoscopic myomectomy (0.97-1.52). Age may influence reintervention rates, and there was variation in hysterectomy risk when stratified by geographical region.
Conclusions: After a median of 7 years of follow-up, there is a 2.4-fold increased rate of hysterectomy and 44% increased risk of UPPs as reintervention after UAE, relative to myomectomy. These findings will aid pre-procedure counselling for women with fibroids. Future work should investigate the effect of other outcome modifiers, such as fertility intentions and fibroid anatomical characteristics.
Keywords: fibroids; leiomyomas; myomectomy; uterine artery embolisation.
© 2023 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.
Comment in
-
The pitfalls of retrospective analysis when assessing long-term outcomes for women with fibroids.BJOG. 2023 Oct;130(11):1430-1431. doi: 10.1111/1471-0528.17585. Epub 2023 Jun 27. BJOG. 2023. PMID: 37366018 No abstract available.
Similar articles
-
Systematic review and meta-analysis of current evidence in uterine artery embolization vs myomectomy for symptomatic uterine fibroids.Sci Rep. 2024 Aug 20;14(1):19252. doi: 10.1038/s41598-024-69754-0. Sci Rep. 2024. PMID: 39164326 Free PMC article.
-
Reintervention Rates After Myomectomy, Endometrial Ablation, and Uterine Artery Embolization for Patients with Uterine Fibroids.J Womens Health (Larchmt). 2018 Oct;27(10):1204-1214. doi: 10.1089/jwh.2017.6752. Epub 2018 Aug 7. J Womens Health (Larchmt). 2018. PMID: 30085898 Free PMC article.
-
Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT.Health Technol Assess. 2022 Apr;26(22):1-74. doi: 10.3310/ZDEG6110. Health Technol Assess. 2022. PMID: 35435818 Free PMC article. Clinical Trial.
-
Comparative Effectiveness of Uterine Leiomyoma Procedures Using a Large Insurance Claims Database.Obstet Gynecol. 2017 Nov;130(5):1047-1056. doi: 10.1097/AOG.0000000000002331. Obstet Gynecol. 2017. PMID: 29016510 Free PMC article.
-
Uterine artery embolization as a treatment option for uterine myomas.Obstet Gynecol Clin North Am. 2006 Mar;33(1):125-44. doi: 10.1016/j.ogc.2005.12.009. Obstet Gynecol Clin North Am. 2006. PMID: 16504811 Review.
Cited by
-
Systematic review and meta-analysis of current evidence in uterine artery embolization vs myomectomy for symptomatic uterine fibroids.Sci Rep. 2024 Aug 20;14(1):19252. doi: 10.1038/s41598-024-69754-0. Sci Rep. 2024. PMID: 39164326 Free PMC article.
-
Oxycodone vs the Combination of Fentanyl and Remifentanil for General Anesthesia in Laparoscopic Uterine Myomas Surgery: A Prospective, Randomized, Controlled Study.Drug Des Devel Ther. 2025 Jun 9;19:4979-4990. doi: 10.2147/DDDT.S524102. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 40521011 Free PMC article. Clinical Trial.
-
Long-Term Risk of Reintervention After Surgical Leiomyoma Treatment in an Integrated Health Care System.Obstet Gynecol. 2024 May 1;143(5):619-626. doi: 10.1097/AOG.0000000000005557. Epub 2024 Mar 28. Obstet Gynecol. 2024. PMID: 38547478 Free PMC article.
-
Opportunities for change and levelling up: a trust wide retrospective analysis of 8 years of laparoscopic and abdominal myomectomy.Facts Views Vis Obgyn. 2024 Jun;16(2):195-201. doi: 10.52054/FVVO.16.2.025. Facts Views Vis Obgyn. 2024. PMID: 38950533 Free PMC article.
-
Laparoscopic continuous seromuscular circumsuture for myomectomy: a real-world, retrospective, East-Asian cohort study.BMJ Open. 2024 Mar 8;14(3):e081550. doi: 10.1136/bmjopen-2023-081550. BMJ Open. 2024. PMID: 38458810 Free PMC article.
References
REFERENCES
-
- Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501-12.
-
- Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100-7.
-
- Wegienka G, Stewart EA, Nicholson WK, Zhang S, Li F, Thomas L, et al. Black women are more likely than white women to schedule a uterine-sparing treatment for Leiomyomas. J Womens Health. 2021;30(3):355-66.
-
- Strand T, Kives S, Leyland N, Ashkenas J, Janiszewski P, Thiel J. Treatment choices in a National Cohort of Canadian women with symptomatic uterine fibroids. J Obstet Gynaecol Can. 2020;42(12):1475-82.e2.
-
- Amoah A, Joseph N, Reap S, Quinn SD. Appraisal of national and international uterine fibroid management guidelines: a systematic review. BJOG. 2022;129(3):356-64.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical